97.7%
Nordic Biosciencesidiopathic pulmonary fibrosis (IPF)NCT02755441NCT01134822NCT01110694PRO-C4
…ne quantifiable? Capitalising on the unique assays available at Nordic Biosciences, the investigators determined if PRO-C4, a serologic marker of …
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…ne quantifiable? Capitalising on the unique assays available at Nordic Biosciences, the investigators determined if PRO-C4, a serologic marker of …